Your browser is no longer supported. Please, upgrade your browser.
Settings
CNAT Conatus Pharmaceuticals Inc. daily Stock Chart
CNAT [NASD]
Conatus Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.26 Insider Own0.40% Shs Outstand25.92M Perf Week3.14%
Market Cap136.08M Forward P/E- EPS next Y-0.80 Insider Trans0.00% Shs Float25.19M Perf Month15.64%
Income-26.70M PEG- EPS next Q-0.26 Inst Own29.00% Short Float3.45% Perf Quarter162.50%
Sales- P/S- EPS this Y10.00% Inst Trans4.04% Short Ratio0.47 Perf Half Y174.87%
Book/sh1.26 P/B4.17 EPS next Y35.20% ROA-75.60% Target Price13.14 Perf Year174.87%
Cash/sh1.20 P/C4.38 EPS next 5Y38.00% ROE-87.40% 52W Range1.45 - 6.30 Perf YTD-0.38%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-16.67% Beta1.46
Dividend %- Quick Ratio8.10 Sales past 5Y- Gross Margin- 52W Low262.07% ATR0.27
Employees25 Current Ratio8.10 Sales Q/Q- Oper. Margin- RSI (14)67.16 Volatility3.86% 6.17%
OptionableYes Debt/Eq0.04 EPS Q/Q0.70% Profit Margin- Rel Volume0.13 Prev Close5.22
ShortableYes LT Debt/Eq0.04 EarningsMar 08 AMC Payout- Avg Volume1.86M Price5.25
Recom1.70 SMA2011.63% SMA5023.25% SMA200102.92% Volume242,856 Change0.57%
Dec-20-16Reiterated Stifel Buy $5 → $7
Dec-20-16Reiterated H.C. Wainwright Buy $9 → $18
Nov-09-16Reiterated Stifel Buy $6 → $5
Jul-01-16Resumed ROTH Capital Buy
Nov-05-15Reiterated Stifel Buy $11 → $9
Sep-22-15Initiated H.C. Wainwright Buy $15
Apr-28-15Initiated Brean Capital Buy $13
Mar-17-15Resumed ROTH Capital Buy $15
Mar-12-15Reiterated Stifel Buy $13 → $11
Jan-09-15Reiterated ROTH Capital Buy $19 → $12
Oct-21-14Initiated MLV & Co Buy $16
Aug-14-14Reiterated Stifel Buy $14 → $13
Aug-19-13Initiated Stifel Buy $16
Feb-17-17 04:06PM  CONATUS PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers
Feb-16-17 04:06PM  CONATUS PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fin
Feb-07-17 07:33AM  CONATUS PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers
07:30AM  Conatus Pharmaceuticals Appoints William R. LaRue as Independent Board Member GlobeNewswire
Feb-06-17 07:30AM  Conatus to Present at BIO CEO & Investor Conference GlobeNewswire +17.01%
Feb-02-17 04:05PM  Conatus Pharmaceuticals Promotes Daniel L. Ripley to Senior Vice President, Business Development, Program and Alliance Management GlobeNewswire
Feb-01-17 04:06PM  CONATUS PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jan-26-17 04:06PM  CONATUS PHARMACEUTICALS INC. Files SEC form 8-K, Termination of a Material Definitive Agreement -5.18%
Jan-13-17 06:45AM  Short Interest In Conatus Pharmaceuticals Surges
Jan-12-17 08:38AM  Henry Schein Hurt by Higher Costs, Lacks Growth Drivers
07:07AM  Walgreens Teams Up with Fedex to Boost Retail Performance
06:46AM  NuVasive at 52-Week High on Preliminary Results, MHLW Nod
Jan-11-17 10:31AM  Can The Uptrend Continue for Conatus (CNAT)?
07:13AM  Align Poised On Global Expansion & Invisalign Teen Growth
Dec-30-16 11:47AM  Traders Are Cleaning Out Their Portfolios
Dec-29-16 01:10PM  Conatus Pharmaceuticals Significant Joint-Venture Review and Analysis of Third Quarter 2016 Results Accesswire
Dec-28-16 09:00AM  Are Options Traders Betting on a Big Move in Conatus Pharmaceuticals (CNAT) Stock? -13.58%
Dec-23-16 11:39AM  Conatus Pharmaceuticals, Inc. :CNAT-US: Earnings Analysis: Q3, 2016 By the Numbers : December 23, 2016 +17.51%
08:40AM  Options Traders Expect Huge Moves in Conatus Pharmaceuticals (CNAT) Stock
Dec-21-16 10:10AM  Company News for December 21, 2016 -8.67%
09:25AM  Biotech Stock Roundup: Conatus Soars on Novartis Deal, Early FDA Nod for Clovis Drug
09:15AM  Today's Reports on Biotech Movers ACADIA Pharmaceuticals and Conatus Pharmaceuticals Accesswire
Dec-20-16 12:00PM  Banking Sector Leading Rally in U.S. Markets +141.33%
10:46AM  General Mills falls on miss, BlackBerry's profit surprise, Facebook faces EU probe over WhatsApp merger
10:37AM  Novartis AG (ADR) (NVS) Agrees To $50 Million Deal With Conatus Pharmaceuticals Inc (CNAT) at Insider Monkey
10:30AM  Conatus Pharma Doubles On Novartis NASH Liver Drug Licensing Deal
08:53AM  Conatus Stock Up on Liver Drug Collaboration with Novartis
08:50AM  Conatus More Than Doubles on Key License Collaboration Agreement
08:15AM  Dow closes in on 20K, Apple talks to India and Uber losses mount
05:54AM  Dow futures point to slow march higher toward key 20,000 mark at MarketWatch
Dec-19-16 10:02PM  Futures Point North; Asia Mixed, Despite European Attacks
05:21PM  Conatus shares skyrocket after Novartis license deal at MarketWatch
04:31PM  CONATUS PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or P
04:30PM  Conatus Announces Exclusive Worldwide Option, Collaboration and License Agreement Covering Development and Commercialization of Emricasan GlobeNewswire
Nov-30-16 01:04PM  CONATUS PHARMACEUTICALS INC. Financials
Nov-14-16 08:00AM  Conatus Pharmaceuticals Announces Poster Presentations at AASLD Annual Meeting GlobeNewswire
Nov-09-16 08:09AM  Conatus (CNAT) Reports Narrower-than-Expected Loss in Q3 +7.05%
07:30AM  Conatus Pharmaceuticals to Present at Stifel 2016 Healthcare Conference GlobeNewswire
Nov-08-16 04:28PM  Conatus reports 3Q loss
04:07PM  CONATUS PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:05PM  Conatus Pharmaceuticals Reports Third Quarter 2016 Financial Results and Program Updates GlobeNewswire
07:07AM  Q3 2016 Conatus Pharmaceuticals Inc Earnings Release - After Market Close
Nov-03-16 07:30AM  Conatus Initiates Phase 2b ENCORE-PH Clinical Trial of Emricasan in Patients with NASH Cirrhosis GlobeNewswire -5.06%
Nov-01-16 04:05PM  Conatus Pharmaceuticals to Report Third Quarter 2016 Financial Results GlobeNewswire -10.73%
Oct-31-16 09:11AM  Conatus (CNAT) Q3 Earnings: What's in Store for the Stock?
Oct-04-16 10:34AM  Why Facebook, Netflix, and Three Other Stocks Are in Spotlight Today at Insider Monkey +6.12%
Oct-03-16 06:13PM  After-hours buzz: QCOM, CNAT & more at CNBC
04:12PM  Conatus Pharmaceuticals Announces Acceptance of Emricasan Abstracts for AASLD Annual Meeting GlobeNewswire
Sep-22-16 03:06PM  Why Collegium Pharmaceuticals Inc (COLL), Galmed Pharmaceuticals Ltd (GLMD) and Three Other Stocks Are Registering Significant Gains Today at Insider Monkey
09:08AM  5 Biotech Stocks to Watch as Interest in NASH Increases
Sep-21-16 12:50AM  [$$] Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal at The Wall Street Journal
Sep-20-16 09:40PM  [$$] Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal at The Wall Street Journal +19.43%
01:02PM  NASH Hype Has These 2 Stocks Soaring, Plus the Latest On MGT Capital, PTC Therapeutics, and Cloud Peak Energy at Insider Monkey
11:46AM  Here's Why Conatus Pharmaceuticals (CNAT) Stock Is Soaring Today
Aug-30-16 11:35AM  Why The Zika News Might Not Be So Great For Conatus Pharmaceuticals Inc (CNAT) at Insider Monkey -6.00%
10:00AM  Spotlight (STLT) to Help Fund Breakthrough Drug Research
12:06AM  [$$] Potential Zika Virus Therapies Identified by Researchers at The Wall Street Journal
Aug-29-16 01:47PM  Conatus Pharmaceuticals (CNAT) Stock Surges, Liver Drug Could Treat Zika +5.26%
08:00AM  Exalenz Bioscience Announces Collaboration with Conatus Pharmaceuticals to Use BreathID® to Monitor Patients with Cirrhosis Associated with NASH PR Newswire
Aug-05-16 04:08PM  CONATUS PHARMACEUTICALS INC. Files SEC form 10-Q, Quarterly Report
Aug-04-16 12:16PM  Conatus (CNAT) Posts Narrower Q2 Loss, Emricasan in Focus -8.86%
Aug-03-16 06:45PM  Conatus reports 2Q loss
04:06PM  CONATUS PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:05PM  Conatus Pharmaceuticals Reports Second Quarter 2016 Financial Results and Program Updates GlobeNewswire
07:07AM  Q2 2016 Conatus Pharmaceuticals Inc Earnings Release - After Market Close
Aug-02-16 10:30AM  Drug Stocks to Watch for Earnings on Aug 3: ZTS, EXEL & More
08:35AM  Medical Product Stocks Earnings Preview for Aug 3: BIO, CSII & More
Aug-01-16 06:36PM  Conatus (CNAT) May Surprise in Q2 Earnings: Stock to Gain?
Jul-27-16 07:30AM  Conatus Pharmaceuticals to Report Second Quarter 2016 Financial Results GlobeNewswire
Jun-24-16 04:06PM  CONATUS PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to
Jun-14-16 07:30AM  Conatus to Present at JMP Securities Life Sciences Conference GlobeNewswire
May-06-16 10:32AM  Conatus (CNAT) Posts In Line Q1 Loss , Focus on Emricasan -8.24%
May-05-16 09:30AM  Conatus' (CNAT) Q1 Loss in Line with Expectation -6.25%
07:40AM  Conatus reports 1Q loss
07:07AM  Q1 2016 Conatus Pharmaceuticals Inc Earnings Release - Before Market Open
07:01AM  CONATUS PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financi
07:00AM  Conatus Pharmaceuticals Reports First Quarter 2016 Financial Results and Program Updates GlobeNewswire
May-04-16 04:05PM  Conatus Extends Positive Results with Emricasan in Phase 2 Liver Cirrhosis Clinical Trial GlobeNewswire
11:25AM  Drug Stocks Earnings Preview: GERN, RPRX, ICPT, AGIO & More Zacks
May-03-16 06:57PM  Conatus (CNAT): Can the Stock Surprise in Q1 Earnings? Zacks
Apr-28-16 07:30AM  Conatus Pharmaceuticals to Report First Quarter 2016 Financial Results GlobeNewswire
Apr-18-16 07:30AM  Conatus Late Breaker Oral Presentation at EASL Details Phase 2 Liver Cirrhosis Trial Three-month Data GlobeNewswire
Apr-15-16 07:30AM  Conatus Poster at EASL Meeting Today Addresses Safety of Caspase Inhibition in Cancer Treatment GlobeNewswire
Apr-06-16 01:47PM  Edited Transcript of CNAT earnings conference call or presentation 9-Mar-16 9:30pm GMT +10.92%
12:25PM  Penny Stocks: Wednesday's List Of Trending Micro Cap And Small Cap Equities Accesswire
Apr-05-16 07:30AM  Conatus to Present at Needham Healthcare Conference GlobeNewswire
Apr-04-16 11:42AM  Penny Stocks To Buy: Traders Are Considering Stocks On This List, Monday 4/4/2016 Accesswire +9.09%
07:30AM  Conatus Pharmaceuticals Appoints Edward F. Smith III as Senior Vice President, Regulatory Affairs and Quality Assurance GlobeNewswire
Mar-30-16 07:50AM  Conatus Pharmaceuticals Announces Acceptance of Abstracts for EASL Meeting at noodls
07:30AM  Conatus Pharmaceuticals Announces Acceptance of Abstracts for EASL Meeting GlobeNewswire
Mar-11-16 04:12PM  CONATUS PHARMACEUTICALS INC. Files SEC form 10-K, Annual Report
Mar-10-16 09:00AM  Conatus' Loss Narrower than Expected, Focus on Emricasan
Mar-09-16 04:53PM  Conatus reports 4Q loss
04:30PM  Conatus Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
04:07PM  CONATUS PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:05PM  Conatus Pharmaceuticals Reports 2015 Financial Results and Program Updates GlobeNewswire
07:07AM  Q4 2015 Conatus Pharmaceuticals Inc Earnings Release - After Market Close
Mar-07-16 10:10AM  Can Conatus (CNAT) Surprise Estimates in Q4 Earnings? +9.27%
Mar-02-16 07:01AM  Conatus Pharmaceuticals to Report Fourth Quarter and Full Year 2015 Financial Results GlobeNewswire +7.87%
Feb-12-16 11:10AM  Propanc Health Group, Top Our List for Investor Potential in Biotech Accesswire
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sustained viral response, non-alcoholic steatohepatitis, and nonalcoholic fatty liver disease and raised transaminases, as well as for the treatment of patients with severe alcoholic hepatitis. The company was founded in 2005 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cashion CharlesSVP, Finance, CFO and Sec.Jan 09Option Exercise0.9942,42442,00042,424Jan 11 04:01 PM
Mento Steven JPresident, CEO & DirectorDec 20Option Exercise1.2141,41450,09141,414Dec 22 04:04 PM
Van Wart HaroldDirectorOct 27Option Exercise0.2518,1814,54518,181Oct 31 04:37 PM